8th Annual OneMedForum San Francisco, 1/12-13/15,
Announces First Group of Presenting Companies

OneMedForum 2015

NEW YORK--()--OneMedForum announced today the first group of presenting companies for its 8th annual conference at the San Francisco Marriott Marquis, Jan. 12-13, 2015.

“In the seven years of doing this conference, I think this is the most robust offering both in terms of diversity and number of companies presenting,” said Brett Johnson, Founder and CEO. The first group of presenting companies includes:

Boston Therapeutics (BTHE): diabetes and inflammatory disease therapeutics. NeoStem (NBS) : restoring damaged or aging tissue. Aeolus Pharmaceuticals (AOLS): treating lung effects of Acute Radiation Syndrome. CorMedix (CRMD): infection and clotting prevention. Mela Sciences (MELA) non-invasive detection of melanoma. SpectraScience (SCIE): colorectal cancer detection. BioLife Solutions (BLFS): cell, tissue, and organ biopreservation. Targeted Medical Pharma (TRGM): amino acid-based medications. Taxus Cardium (CXM): wound-healing and cardiovascular indications. Titan Pharmaceuticals (TTP): central nervous system disorders, cancer and cardiovascular disease. CombiMatrix (CBMX) prenatal diagnosis and pediatric developmental disorders. Adamis Pharmaceuticals (ADMP): respiratory disease, oncology, and immunology treatments. ARCA Biopharma (ABIO): genetically targeted therapies for cardiovascular diseases. Sorrento Therapeutics (SNRE): targeted therapeutics against a variety of cancers. Biocept Laboratories: biomarkers for tumor-associated DNA. NeuroTronik: neuromodulation treatment for acute heart failure syndrome. ClearFlow: clearing internally obstructed medical tubes. Enable Injections: high viscosity/volume medications to subcutaneous tissue. VisionScope Technologies: diagnostic tools for direct intra-articular visualization. Interface Biologics: reducing thrombosis in blood contacting medical devices. Need It Now: iOS application and sales/marketing platform for medical technologies. Soft Tissue Regeneration: biologics for regeneration and repair of joint tissue. POC Medical Systems: screening tools for breast cancer detection. Colby Pharmaceuticals: oral and injection treatments for infectious disease. Implandata Ophthalmic: diagnosing and monitoring glaucoma. Wellesley Pharmaceuticals: nocturia treatment. Cerora: device and software platform for brain injury detection. Profound Medical : minimally invasive treatment for prostate cancer. Taragenyx: using engineering and biology to develop new medical implants. CellAegis: reducing damage to organs during surgery or trauma. EndoSphere Surgical: high-definition technology that laparoscopic surgery. Endomag: magnetic technology to power diagnostic and therapeutic devices. Hemosonics: stopping blood loss in surgery and trauma. Micro Interventional Devices: minimally invasive structural heart repair procedures. Wholesale Change connecting providers and insurers of care. BEAT BioTherapeutics: developing a new drug to treat heart failure. Diffusion Pharmaceuticals: treatment of cancer and heart disease.

Public company presentations will be webcast live on OneMedTV beginning at 9 a.m. PST on January 12, 2015.

Active institutional investors can apply for a complementary pass to company sessions/exhibits at www.onemedconferences.com.

Contacts

Ronald Trahan Associates Inc.
Ronald Trahan, APR, +508-359-4005, x108

Release Summary

8th Annual OneMedForum San Francisco, 1/12-13/15, Announces First Group of Presenting Companies

Contacts

Ronald Trahan Associates Inc.
Ronald Trahan, APR, +508-359-4005, x108